Literature DB >> 1716396

Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta.

S Kamimura1, K Eguchi, M Yonezawa, K Sekiba.   

Abstract

Previously, we pointed out the importance of the kynurenine metabolism in fetuses and neonates. We examined localization and developmental change of indoleamine 2,3-dioxygenase activity in human placenta. The indoleamine 2,3-dioxygenase was found localized in syncytiotrophoblast in the placenta. The indoleamine 2,3-dioxygenase activity was not detected in placenta in the early stage of gestation. It was first detected at around 14 weeks of gestation, increased rapidly thereafter and was maintained at high levels till near term. The indoleamine 2,3-dioxygenase activity was significantly lower in placenta with retarded intrauterine development. These results suggest the importance of placental indoleamine 2,3-dioxygenase during fetal development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716396     DOI: 10.18926/AMO/32206

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  17 in total

Review 1.  Immunology of pregnancy. Implications for the mother.

Authors:  Jill A Poole; Henry N Claman
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

Review 2.  Innate immunity, decidual cells, and preeclampsia.

Authors:  Chang-Ching Yeh; Kuan-Chong Chao; S Joseph Huang
Journal:  Reprod Sci       Date:  2012-07-18       Impact factor: 3.060

Review 3.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 4.  Physiological and molecular determinants of embryo implantation.

Authors:  Shuang Zhang; Haiyan Lin; Shuangbo Kong; Shumin Wang; Hongmei Wang; Haibin Wang; D Randall Armant
Journal:  Mol Aspects Med       Date:  2013-01-02

Review 5.  Placental expression of indoleamine 2,3-dioxygenase.

Authors:  Peter Sedlmayr; Astrid Blaschitz
Journal:  Wien Med Wochenschr       Date:  2012-05

6.  Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti.

Authors:  S Suzuki; S Toné; O Takikawa; T Kubo; I Kohno; Y Minatogawa
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

7.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

8.  Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes.

Authors:  Mark K Santillan; Christopher J Pelham; Pimonrat Ketsawatsomkron; Donna A Santillan; Deborah R Davis; Eric J Devor; Katherine N Gibson-Corley; Sabrina M Scroggins; Justin L Grobe; Baoli Yang; Steven K Hunter; Curt D Sigmund
Journal:  Physiol Rep       Date:  2015-01-19

9.  Manifestations of immune tolerance in the human female reproductive tract.

Authors:  Gary F Clark; Danny J Schust
Journal:  Front Immunol       Date:  2013-02-13       Impact factor: 7.561

10.  Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Authors:  Peter Terness; Thomas M Bauer; Lars Röse; Christoph Dufter; Andrea Watzlik; Helmut Simon; Gerhard Opelz
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.